Q3 2020 Holdings
Filed 2020-11-13 | 64 holdings | $607.3M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Ascendis Pharma A/S(ASND) | SPONSORED ADR | 04351P101 | $277.4M | 1,797,745 | 45.7% |
| ALX Oncology Hldgs Inc(ALXO) | Common | 00166B105 | $159.3M | 4,220,048 | 26.2% |
| Crinetics Pharmaceuticals in(CRNX) | Common | 22663K107 | $35.5M | 2,263,770 | 5.8% |
| Arcutis Biotherapeutics Inc(ARQT) | Common | 03969K108 | $32.6M | 1,113,265 | 5.4% |
| Celldex Therapeutics Inc New(CLDX) | Common | 15117B202 | $25.5M | 1,722,500 | 4.2% |
| Arrowhead Pharmaceuticals in(ARWR) | Common | 04280A100 | $24.8M | 576,505 | 4.1% |
| Codexis Inc(CDXS) | Common | 192005106 | $17.3M | 1,476,289 | 2.9% |
| Cytokinetics Inc(CYTK) | Common | 23282W605 | $15.2M | 700,000 | 2.5% |
| Aurinia Pharmaceuticals Inc(AUPH) | Common | 05156V102 | $7.4M | 500,732 | 1.2% |
| Black Diamond Therapeutics I(BDTX) | Common | 09203E105 | $4.4M | 145,417 | 0.7% |
| Aclaris Therapeutics Inc(ACRS) | Common | 00461U105 | $4.2M | 1,647,214 | 0.7% |
| Atricure Inc(ATRC) | Common | 04963C209 | $2.6M | 64,573 | 0.4% |
| Harmony Biosciences Hldgs in(HRMY) | Common | 413197104 | $153.7K | 4,534,341 | 0.0% |
| New Frontier Health Corp | Ord Shs | G6461G106 | $109.1K | 14,300,000 | 0.0% |
| Legend Biotech Corp(LEGN) | SPONSORED ADS | 52490G102 | $102.8K | 3,330,269 | 0.0% |
| Genetron Hldgs LTD | ADS | 37186H100 | $75.7K | 6,339,860 | 0.0% |
| Amyris Inc(AMRSEUR) | Common | 03236M200 | $38.4K | 13,158,914 | 0.0% |
| Sinovac Biotech LTD(SVA) | SHS | P8696W104 | $38.2K | 5,900,000 | 0.0% |
| Immunovant Inc(IMVT) | Common | 45258J102 | $36.7K | 1,042,460 | 0.0% |
| Iveric BIO Inc(OPHTEUR) | Common | 46583P102 | $33.7K | 5,966,527 | 0.0% |
| Kura Oncology Inc(KURA) | Common | 50127T109 | $32.2K | 1,050,000 | 0.0% |
| Zymeworks Inc | Common | 98985W102 | $29.8K | 640,411 | 0.0% |
| Passage BIO Inc | Common | 702712100 | $28.7K | 2,191,453 | 0.0% |
| Sage Therapeutics Inc(SG7) | Common | 78667J108 | $21.6K | 353,511 | 0.0% |
| Myokardia Inc | Common | 62857M105 | $21.6K | 158,310 | 0.0% |
| Kadmon Hldgs Inc(KDMN) | Common | 48283N106 | $20.7K | 5,291,336 | 0.0% |
| Sierra Oncology Inc | Common | 82640U404 | $20.5K | 1,917,074 | 0.0% |
| Rocket Pharmaceuticals Inc(RCKT) | Common | 77313F106 | $19.7K | 860,648 | 0.0% |
| Verona Pharma PLC(VRNA) | SPONSORED ADS | 925050106 | $19.0K | 3,048,507 | 0.0% |
| Kalvista Pharmaceuticals Inc(KALV) | Common | 483497103 | $18.6K | 1,476,796 | 0.0% |
| Novavax Inc(NVAX) | Common | 670002401 | $17.8K | 164,199 | 0.0% |
| Avadel Pharmaceuticals PLC | SPONSORED ADR | 05337M104 | $17.8K | 3,526,093 | 0.0% |
| Kiniksa Pharmaceuticals LTD | Common | G5269C101 | $17.6K | 1,151,622 | 0.0% |
| Akero Therapeutics Inc(AKRO) | Common | 00973Y108 | $17.6K | 571,833 | 0.0% |
| Mereo Biopharma Group PLC(MREO) | ADS | 589492107 | $16.3K | 6,220,938 | 0.0% |
| Nkarta Inc(NKTX) | Common | 65487U108 | $15.4K | 512,225 | 0.0% |
| Cymabay Therapeutics Inc(CBAYUSD) | Common | 23257D103 | $15.1K | 2,089,356 | 0.0% |
| Zogenix Inc | Common | 98978L204 | $14.7K | 817,935 | 0.0% |
| Eiger Biopharmaceuticals Inc(CLDNEUR) | Common | 28249U105 | $14.6K | 1,791,257 | 0.0% |
| Calliditas Therapeutics AB | SPONSORED ADS | 13124Q106 | $13.9K | 580,000 | 0.0% |
| Aduro Biotech Inc(ADROEUR) | Common | 00739L101 | $12.4K | 5,118,560 | 0.0% |
| Larimar Therapeutics Inc(LRMR) | Common | 517125100 | $12.1K | 799,662 | 0.0% |
| Essa Pharma Inc(EPIEUR) | Common | 29668H708 | $10.5K | 1,516,865 | 0.0% |
| ZAI LAB LTD(ZLAB) | ADR | 98887Q104 | $10.2K | 122,107 | 0.0% |
| Homology Medicines Inc | Common | 438083107 | $9.1K | 853,143 | 0.0% |
| Matinas Biopharma Hldgs Inc | Common | 576810105 | $8.6K | 11,279,323 | 0.0% |
| Poseida Therapeutics Inc(PSTXUSD) | Common | 73730P108 | $8.2K | 926,449 | 0.0% |
| Curevac N V | Common | N2451R105 | $7.9K | 169,825 | 0.0% |
| IGM Biosciences Inc(1K0) | Common | 449585108 | $7.6K | 103,480 | 0.0% |
| Ovid Therapeutics Inc(OVID) | Common | 690469101 | $7.2K | 1,250,000 | 0.0% |